Elbow Artery Embolization for Tennis Elbow
NCT: NCT05325242 · ACTIVE_NOT_RECRUITING
Brief Summary
The purpose of this clinical research study is to examine whether embolization treatment of an elbow artery is a safe and effective way to treat elbow pain, specifically pain from tennis elbow. Embozene is a medical device made by Varian marketed in the United States for the treatment of hypervascular tumors and arteriovenous malformations. It consists of thousands of microscopic spheres that are injected into the artery to block the flow of blood to a specific region. One of the causes of pain in the setting of tennis elbow is increased blood flow going to the specific area of pain. In this study, we will investigate an experimental procedure to decrease the blood flow (embolize) to the specific region of the elbow that is causing the pain. This will be done by infusing Embozene particles into the specific blood vessel supplying the area of pain in the elbow. This is an investigational study to evaluate the safety and efficacy of elbow artery embolization (EAE) for the treatment of symptomatic lateral epicondylitis (tennis elbow).
Frequently Asked Questions
What is Elbow Artery Embolization for Tennis Elbow?
Elbow Artery Embolization for Tennis Elbow is a clinical trial registered under NCT05325242. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05325242?
The current status of NCT05325242 (Elbow Artery Embolization for Tennis Elbow) is: ACTIVE_NOT_RECRUITING.
When did Elbow Artery Embolization for Tennis Elbow start?
Elbow Artery Embolization for Tennis Elbow started on 2023-03-21.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.